(redirected from Abacavir)
Also found in: Dictionary, Medical, Acronyms, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for lamivudine

a nucleoside reverse transcriptase inhibitor that is very effective in combination with zidovudine in treating AIDS and HIV

References in periodicals archive ?
Following a hypersensitivity reaction to abacavir, NEVER restart Triumeq or any other abacavir-containing product.
15) None of them turned up any evidence that abacavir predisposes people to heart attacks.
HLA-B*5701 screening for hypersensitivity to abacavir.
ii) Currently available tablet formulations of abacavir, efavirenz, LPV/rtv (Aluvia[R]) and AZT are film-coated and must be swallowed whole and not chewed, divided or crushed.
Original description of the association of abacavir hypersensitivity with HLA alleles.
Results from the study suggested that use of abacavir within the previous six months is associated with an increased risk of myocardial infarction," the statement said.
They will be compared to 200 of each race who have taken abacavir for at least 12 weeks without hypersensitivity.
The approval of abacavir and lamivudine tablets for oral suspension for marketing in developing markets demonstrates our commitment to providing the world's 7 billion people with access to medicine and our continued leadership in enhancing access to ARVs to patients in developing countries," Mylan CEO Heather Bresch said.
Abacavir (ABC), a nucleoside reverse transcriptase inhibitor (NRTI), has been shown to be an effective component of combination antiretroviral therapy (ART) regimens for both paediatric and adult patients.
Six studies (some not yet published) now have shown increased risk of MI with short-term abacavir, while three studies found no association between short-term abacavir and MI risk.
Mascolini: At the other end of the treatment spectrum, for people with little or no treatment experience, what's your thinking on using abacavir versus tenofovir versus NRTI-sparing regimens?
The controversy surrounding the clinical significance of the possible intracellular interaction between abacavir and ribavirin phosphorylation continues.
A similar combination (tenofovir plus abacavir plus ddI) also failed.
From abacavir to zuclopenthixol, some 600 substances are covered, 139 of which are new to this edition and include animal toxins, antibiotics, antidepressants, antifungal agents, antiviral agents, diuretics, herbal medicines, herbicides, laxatives, solvents, sedative- hypnotics, pesticides, and drugs used to treat Alzheimer's disease.